Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 8

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastrointest Oncol. Aug 15, 2017; 9(8): 333-340
Published online Aug 15, 2017. doi: 10.4251/wjgo.v9.i8.333

Table 1 Patient characteristics n (%)

¹PS unknown or 3 in < 1% of all patients;

²Data was unavailable for one patient in the SCC group. SCC: Squamous cell carcinoma; OGJ: Oesophagogastric junction.

Citation: Davidson M, Chau I, Cunningham D, Khabra K, Iveson T, Hickish T, Seymour M, Starling N. Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer. World J Gastrointest Oncol 2017; 9(8): 333-340
URL: https://www.wjgnet.com/1948-5204/full/v9/i8/333.htm
DOI: https://dx.doi.org/10.4251/wjgo.v9.i8.333

Davidson M, Chau I, Cunningham D, Khabra K, Iveson T, Hickish T, Seymour M, Starling N. Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer. World J Gastrointest Oncol 2017; 9(8): 333-340 [PMID: 28868114 DOI: 10.4251/wjgo.v9.i8.333]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.